ArticleAnnals of medicine and surgery (2012)2025
Protecting developing brains: urgent need to regulate synthetic food dyes in children's diets.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthetic food dyes remain prevalent in children's diets despite growing evidence linking them to adverse neurodevelopmental outcomes, including exacerbation of Attention-Deficit Hyperactivity Disorder (ADHD) symptoms. Recent systematic reviews and meta-analyses indicate associations between dye exposure and behavioral changes, with mechanisms involving oxidative stress, mitochondrial dysfunction, and disruption of dopamine and serotonin metabolism leading to neuroinflammation and impaired impulse control. Current safety standards, such as Acceptable Daily Intakes (ADIs), rely on outdated toxicological data and fail to account for cumulative effects or neurobehavioral endpoints. Regulatory inconsistencies, industry resistance, and inadequate labeling hinder effective control. We advocate for updated FDA and EFSA guidelines, reformulation incentives for manufacturers, improved labeling, and public health campaigns promoting natural colorants and additive-free diets. Urgent action is required to protect developing brains and prioritize neurological safety over aesthetic appeal in children's food products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.